Clinical Trials | April 30, 2026
Pfizer drug delivers breakthrough in late-stage blood cancer trial
Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis
Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis
By cutting pain crises & boosting haemoglobin
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
Medical experts point to a growing body of research linking energy drinks to liver injury
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
_256_384.jpg)
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
